EUVIMEDOpdag EUVIMED
Crossref

MECP2 Mutations or Polymorphisms in Mentally Retarded Boys

Violaine Bourdon, Christophe Philippe, Dominique Martin, Alain Verloès, Agnès Grandemenge, Philippe Jonveaux

Molecular Diagnosis · 2003

DOI: 10.1007/bf03260014 ↗

At a glance

Journal article in Molecular Diagnosis, 2003. Written by Violaine Bourdon and 5 co-authors. Institution: Laboratory of Medical Genetics, EA 3441, CHU-Brabois, Vandoeuvre-Lès Nancy, France. Major MEDLINE topics: Polymorphism, Genetic. Cited 3 times so far (Crossref); 30 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: Among the well characterized X-linked conditions causing mental retardation, mutations in the methyl-CpG-binding protein 2 gene (MECP2) in Xq28 have been found in up to 85% of patients with Rett syndrome, a neurologic disorder which, in addition to other symptoms, severely affects higher cognitive functions in females. Mutations in the MECP2 gene are involved in a broad spectrum of phenotypes from classical Rett syndrome to mild intellectual difficulties in females and neonatal encephalopathy in males. Recently, mutations in the MECP2 gene were reported in males with non-specific mental retardation suggesting that defects in MECP2 could be responsible for up to 2% of X-linked mental retardation. METHODS: We screened by denaturing high-pressure liquid chromatography the entire coding region and flanking intronic sequences of the MECP2 gene in a cohort of 354 mentally retarded males found negative for an expansion across the FRAXA CGG repeat and in a family in which a boy and his sister were mentally retarded. RESULTS: We identified mainly silent polymorphisms within the MECP2 gene, together with four sequence alterations of unknown significance, i.e. three missense mutations (T197M, T228S, and P376S) and one substitution at position -19 in intron 3 (378-19delT). Further familial investigations allowed us to ruled out a pathogenic effect for the intronic variant, the T228S and the P376S missense mutations. CONCLUSIONS: These results confirm that MECP2 mutations in males are far more rare than initially thought and call for a careful evaluation of the pathogenicity of the MECP2 missense mutations identified in mentally retarded males before genetic counseling is proposed to the relatives.

Subjects

MeSH terms (MEDLINE)

Polymorphism, GeneticChromatography, High Pressure LiquidChromosomal Proteins, Non-HistoneChromosomes, Human, XDNA-Binding ProteinsFemaleHumansIntellectual DisabilityMaleMethyl-CpG-Binding Protein 2MutationPedigreeRepressor Proteins

Substances

Chromosomal Proteins, Non-HistoneDNA-Binding ProteinsMECP2 protein, humanMethyl-CpG-Binding Protein 2Repressor Proteins

Authors and institutions

  • Laboratory of Medical Genetics, EA 3441, CHU-Brabois, Vandoeuvre-Lès Nancy, France.

Cite

APA

Bourdon, V., Philippe, C., Martin, D., Verloès, A., Grandemenge, A., & Jonveaux, P. (2003). MECP2 Mutations or Polymorphisms in Mentally Retarded Boys. Molecular Diagnosis. https://doi.org/10.1007/bf03260014

Vancouver

Bourdon V, Philippe C, Martin D, Verloès A, Grandemenge A, Jonveaux P. MECP2 Mutations or Polymorphisms in Mentally Retarded Boys. Molecular Diagnosis. 2003. doi:10.1007/bf03260014

BibTeX
@article{Bourdon2003,
  author = {Bourdon, Violaine and Philippe, Christophe and Martin, Dominique and Verloès, Alain and Grandemenge, Agnès and Jonveaux, Philippe},
  title = {MECP2 Mutations or Polymorphisms in Mentally Retarded Boys},
  journal = {Molecular Diagnosis},
  year = {2003},
  doi = {10.1007/bf03260014}
}
Start for free →